Neurology
Researchers' data from South Korea and Japan advance neurology research
Published in Genomics and Genetics Weekly, June 16th, 2006
Study 1: Neuroblastoma could be inhibited by arsenic trioxide (As2 O3 ).
According to recent research published in the journal Pediatric Hematology and Oncology, "Neuroblastoma, characterized by heterogeneous cell population, is a common solid tumor in childhood and some malignant neuroblastomas are refractory to conventional chemotherapy. Recently, treatment with As2 O3 was found effective in the treatment of acute promyelocytic leukemia as well as neuroblastoma cells by inducing apoptosis."
"To define the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genomics and Genetics Weekly
More Articles from Genomics and Genetics Weekly
- Adenocarcinoma
Adenocarcinoma of esophagus and gastroesophageal junction linked to alteration of 1q and 8p genes - Genetics & Genomics
Acute cardiac overload alters myocardial gene expression profile - Genetics & Genomics
PRAF2 genomic organization and expression characterized - Genetics & Genomics
Viral gene expression activation identified in polarized epithelial monolayers - Hepatocellular Cancer
Hepatocellular cancer malignancy linked to reduced copy number of mitochondrial DNA - Adenoviral Gene Therapy
Adenovirus-mediated gene expression is improved by a polyethylene glycol vehicle - More from this issue of Genomics and Genetics Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
